虽然重组人生长激素（rhGh）和重组胰岛素样生长因子-I（rhIGF-I）都有提供临床益处的潜力，但它们也都有可能产生不良副作用。 - Suppr

Although both rhGh and rhIGF-I have the potential to provide clinical benefit, each also has the potential to produce unwanted side-effects.

Le Roith D

Growth Horm IGF Res. 1999 Apr;9(2):83. doi: 10.1054/ghir.1999.0103.

Abstract

摘要

Growth Horm IGF Res. 1999 Apr;9(2):83. doi: 10.1054/ghir.1999.0103.

J Pediatr Endocrinol Metab. 1999 Apr;12 Suppl 1:259-66.

Adv Ther. 2008 Dec;25(12):1276-87. doi: 10.1007/s12325-008-0124-9.

Med Monatsschr Pharm. 1986 Nov;9(11):345-6.

Trends Endocrinol Metab. 2005 May-Jun;16(4):190-7. doi: 10.1016/j.tem.2005.03.011.

Endocr Dev. 2009;14:135-42. doi: 10.1159/000207482. Epub 2009 Feb 27.

Clin Ther. 2007 Nov;29(11):2269-88. doi: 10.1016/j.clinthera.2007.11.004.

Curr Opin Investig Drugs. 2008 Sep;9(9):983-92.

Acta Paediatr Suppl. 1992 Sep;383:134-6.

Pediatr Crit Care Med. 2008 Mar;9(2):209-16. doi: 10.1097/PCC.0b013e318166d414.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。